Stay updated on RESDEX Clinical Trial
Sign up to get notified when there's something new on the RESDEX Clinical Trial page.

Latest updates to the RESDEX Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes regarding the use of dexamethasone (DEX) in glioblastoma treatment, emphasizing a restrictive regimen based on clinical criteria, while removing extensive background information on the standard use of DEX and its associated risks.SummaryDifference30%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to RESDEX Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RESDEX Clinical Trial page.